Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Corticobasal Degeneration clinical trials
6 of 8 indexed Corticobasal Degeneration trials are currently recruiting.
Corpus placement: #2,176 of 28,707 conditions by registered trial count.
8 US clinical trials · 6 currently recruiting · #2,176 of 28,707 conditions by registered trial count
Corticobasal Degeneration: 8 US clinical trials tracked, 6 recruiting.
Corticobasal Degeneration is the subject of 8 registered US clinical trials on ClinicalTrials.gov, 6 of them currently open to new participants. The most active sponsor is Massachusetts General Hospital, running 2 of these trials.
Enrollment posture brief
Registry condition corticobasal-degeneration
OPEN 6 | RECR 75% | LATE 0 | EARLY 0 | RANK #2176 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Adolescent Idiopathic Scoliosis (75% recruiting · 8 trials)
Corticobasal Degeneration lists 6 open slots (75% of 8 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Corticobasal Degeneration on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Corticobasal Degeneration is recruiting above its size-band peers.
6 of 8 indexed trials (75%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Corticobasal Degeneration research.
Massachusetts General Hospital accounts for 2 of 8 trials (25%). 7 distinct sponsors appear on at least one study for this condition label.
-
Typical Corticobasal Degeneration enrolment sits around 632 participants.
Median target enrolment is 632 among the 8 trials that report a genuine target (sentinel values excluded). 3 of those (37.5%) plan for fewer than 100 participants.
-
Corticobasal Degeneration research leans observational.
2 interventional and 6 observational studies make up this index (25% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
8 total, page 1 of 1
NYSCF Scientific Discovery Biobank
New York Stem Cell Foundation Research Institute
NCT06203106
Modifiable Variables in Parkinsonism (MVP)
Bastyr University
NCT02194816
The CurePSP Genetics Program
Massachusetts General Hospital
NCT06647641
Gait Analysis in Neurological Disease
Beth Israel Deaconess Medical Center
NCT02994719
Imaging Studies in Corticobasal Syndrome
Jennifer Whitwell
NCT07000851
Scrambler Therapy for Corticobasal Syndrome-Associated Pain
Johns Hopkins University
NCT05653778
Community Outreach for Palliative Engagement -- Parkinson Disease
University of Rochester
NCT05222386
A Multi-Modal Remote Monitoring Platform for Frontotemporal Lobar Degeneration (FTLD) Syndromes
Massachusetts General Hospital
NCT05956834
Phase Distribution
Phase data not available
Top Sponsors
Named interventions
Most-linked intervention names on Corticobasal Degeneration records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Corticobasal Degeneration trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Corticobasal Degeneration page
8 registered trials, 6 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 6 Corticobasal Degeneration trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Massachusetts General Hospital sponsors the most Corticobasal Degeneration trials on record, review their full trial history before evaluating a specific study. See Massachusetts General Hospital's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Corticobasal Degeneration condition card totals 8 registered trials; most-linked intervention Online Community-Supported Palliative Care; top US site state Massachusetts. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.